Policy and oversight related to generic and biosimilar industry issues.
2025 · 1st Quarter (Jan 1 - Mar 31)
FRESENIUS KABI USA LLC
Filed by FEROX STRATEGIES.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Mar 18, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- FEROX STRATEGIES
- Client
- FRESENIUS KABI USA LLC
- Filing UUID
- 712e4f9c-16f8-4b39-a541-a0116e85e38e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Policy and oversight related to generic and biosimilar industry issues.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.